{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:13:09Z","timestamp":1783969989781,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejmech.2019.112022","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T18:31:37Z","timestamp":1577730697000},"page":"112022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6621-6790","authenticated-orcid":false,"given":"Wenjie","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4356-3615","authenticated-orcid":false,"given":"Hongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5273-1815","authenticated-orcid":false,"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2667-5877","authenticated-orcid":false,"given":"Johannes","family":"Kirchmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9567-3763","authenticated-orcid":false,"given":"Jie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.112022_bib1","article-title":"Bacterial lipoprotein biosynthetic pathway as a potential target for structure-based design of antibacterial agents","author":"Xia","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.112022_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! an update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis. : Off. Publ. Infect. Dis. Soci. Am."},{"key":"10.1016\/j.ejmech.2019.112022_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd4675","article-title":"Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?","volume":"14","author":"Brown","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.112022_bib6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature17042","article-title":"Antibacterial drug discovery in the resistance era","volume":"529","author":"Brown","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.112022_bib7","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/cmdc.200800217","article-title":"Discovery of novel anticancer compounds based on a quinoxalinehydrazine pharmacophore","volume":"3","author":"Deng","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.112022_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nchembio.534","article-title":"A\u00a0whole-organism screen identifies new regulators of fat storage","volume":"7","author":"Lemieux","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2019.112022_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cmdc.200500018","article-title":"Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors","volume":"1","author":"Dayam","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.112022_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tube.2009.07.006","article-title":"Antituberculosis activity of the molecular libraries screening center network library","volume":"89","author":"Maddry","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2019.112022_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tube.2013.12.001","article-title":"Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis","volume":"94","author":"Ekins","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.ejmech.2019.112022_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10593-007-0137-3","article-title":"4-Hydroxy-2-quinolones. 122. 1-Hydroxy-3-oxo-5,6-dihydro-3H-pyrrolo[3,2,1- ij]-quinoline-2-carboxylic acid hetarylamides as potential antitubercular agents","volume":"43","author":"Ukrainets","year":"2007","journal-title":"Chem. Heterocycl. Comp."},{"key":"10.1016\/j.ejmech.2019.112022_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1177\/1087057108329452","article-title":"Comparison of 3 cytotoxicity screening assays and their application to the selection of novel antibacterial hits","volume":"14","author":"Peternel","year":"2009","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2019.112022_bib14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1023\/A:1012464204563","article-title":"Crystalline and molecular structure of 2-Amino-5-phenyl-1, 3, 4-thiadiazole","volume":"37","author":"Ishankhodzhaeva","year":"2001","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.109.153320","article-title":"1,4-Diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) enhances the cytotoxicity of combretastatin A4 independently of mitogen-activated protein kinase kinase","volume":"330","author":"Quan","year":"2009","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejmech.2019.112022_bib16","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1021\/acs.jmedchem.7b01704","article-title":"Rational design of dimeric lysine N-alkylamides as potent and broad-spectrum antibacterial agents","volume":"61","author":"Niu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib17","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.1021\/acs.jmedchem.5b00443","article-title":"Membrane active small molecules show selective broad spectrum antibacterial activity with No detectable resistance and eradicate biofilms","volume":"58","author":"Hoque","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib18","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1021\/jm500270w","article-title":"Membrane active vancomycin analogues: a strategy to combat bacterial resistance","volume":"57","author":"Yarlagadda","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in\u00a0vitro drug metabolism data in predicting in\u00a0vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.112022_bib20","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/acs.jmedchem.8b01750","article-title":"Design, synthesis, and biological evaluation of novel DNA gyrase-inhibiting spiropyrimidinetriones as potent antibiotics for treatment of infections caused by multidrug-resistant gram-positive bacteria","volume":"62","author":"Shi","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/jac\/dkw061","article-title":"Biological profiling of novel tricyclic inhibitors of bacterial DNA gyrase and topoisomerase IV","volume":"71","author":"Savage","year":"2016","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.112022_bib22","article-title":"Review of guidelines for dental antibiotic prophylaxis for prevention of endocarditis and prosthetic joint infections and need for dental stewardship","author":"Goff","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.112022_bib23","article-title":"Guideline for antibacterial prophylaxis Administration in pediatric cancer and hematopoietic stem cell transplantation","author":"Lehrnbecher","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2019.112022_bib24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/jps.21916","article-title":"Significance of protein binding in pharmacokinetics and pharmacodynamics","volume":"99","author":"Schmidt","year":"2010","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.ejmech.2019.112022_bib25","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1021\/jm0311184","article-title":"Functionality maps of the ATP binding site of DNA gyrase B: generation of a consensus model of ligand binding","volume":"47","author":"Schechner","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib26","doi-asserted-by":"crossref","first-page":"17221","DOI":"10.1021\/jacs.7b07736","article-title":"The antibiotic novobiocin binds and activates the ATPase that powers lipopolysaccharide transport","volume":"139","author":"May","year":"2017","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.112022_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejmech.2016.03.079","article-title":"New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase","volume":"117","author":"Zidar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib28","doi-asserted-by":"crossref","first-page":"W612","DOI":"10.1093\/nar\/gkv352","article-title":"ChEMBL web services: streamlining access to drug discovery data and utilities","volume":"43","author":"Davies","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2019.112022_bib29","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2019.112022_bib30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1021\/acsmedchemlett.5b00368","article-title":"Discovery of pyrazolopyridones as a novel class of gyrase B inhibitors using structure guided design","volume":"7","author":"Cross","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.112022_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bmcl.2013.12.080","article-title":"Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy","volume":"24","author":"Kale","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.112022_bib32","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/jac\/dkr247","article-title":"Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics","volume":"66","author":"Alt","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2019.112022_bib33","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1021\/acs.jmedchem.5b00961","article-title":"Discovery of azaindole ureas as a novel class of bacterial gyrase B inhibitors","volume":"58","author":"Zhang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/ja.2017.30","article-title":"The antibiotic resistance crisis, with a focus on the United States","volume":"70","author":"Martens","year":"2017","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2019.112022_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10593-009-0327-2","article-title":"4-hydroxy-2-quinolones 165*. 1-R-4-hydroxy-2-oxo-1, 2-dihydro-quinoline-3-carbaldehydes and their thiosemicarbazones. Synthesis, structure, and biological properties","volume":"45","author":"Ukrainets","year":"2009","journal-title":"Chem. Heterocycl. Comp."},{"key":"10.1016\/j.ejmech.2019.112022_bib36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jhet.5570160817","article-title":"The chemistry of 2H-3,1-benzoxazine-2,4(1H)dione (isatoic anhydride). 7. Reactions with anions of active methylenes to form quinolines","volume":"16","author":"Coppola","year":"1979","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2019.112022_bib37","volume":"vol. 26","author":"Wikler","year":"2006"},{"key":"10.1016\/j.ejmech.2019.112022_bib38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1744-7348.1935.tb07713.x","article-title":"The Calculation of the dosage-mortality curve","volume":"22","author":"Bliss","year":"1935","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.ejmech.2019.112022_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2019.112022_bib40","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/ci100436p","article-title":"FRED pose prediction and virtual screening accuracy","volume":"51","author":"McGann","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419311808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419311808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:04:26Z","timestamp":1759327466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419311808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":39,"alternative-id":["S0223523419311808"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.112022","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-thiadiazole-4-hydroxy-2-quinolone-3-carboxamides bearing heteroaromatic rings as novel antibacterial agents: Design, synthesis, biological evaluation and target identification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.112022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112022"}}